State Health Planning Commission: Average Outpatient Expenses for Hospitals in 2016: 245.5 Yuan

Release time:


The National Health and Family Planning Commission recently issued a statistical bulletin. Data show that the proportion of personal health expenditure in my country continued to decline last year, and the increase in patient medical expenses fell. The health level of residents is constantly improving, and the main health indicators of residents are generally better than the average level of middle-and high-income countries.

In 2016, the average outpatient cost of hospitals in China was 245.5 yuan, up 5 percent from 2015, down 1.3 percentage points from the previous year, and the per capita hospitalization cost was 8604.7 yuan, up 4.1 percent from 2015, down 2.1 percentage points from the previous year. Among them, the per capita hospital drug cost was 2977.5 yuan, accounting for 34.6 percent, down 2.2 percentage points from the previous year, showing a negative growth for the first time in five years. The total national health expenditure is expected to reach 4634.49 billion billion yuan in 2016, of which personal health expenditure is 1333.79 billion billion yuan, the proportion decreased from 29.3 in 2015 to 28.8 in 2016. In 2016, the reform of public hospitals made positive progress in controlling patient costs, and the increase in medical expenses decreased significantly. In 2016, the pilot reform of urban public hospitals was expanded to 200, and 90.9 percent of the pilot public hospitals canceled all drug markups, and the decline in drug costs in large hospitals led to a decline in the overall increase in medical costs.

Yao Jianhong, inspector of the Department of system reform of the national health and Family Planning Commission: the most important key link is to cancel the drug bonus. According to our established work goal, all public hospitals in the country will cancel the drug bonus by the end of September. We also require that by the end of this year, the increase in medical expenses should be controlled below 10%, so these measures can further control the increase in our medical expenses, and the results of our medical reform can also be transformed into benefits for the masses.